Prescription drug · BLA
Humira (Adalimumab) NDC 50090-4487
Kit · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-4487-0 | 50090448700 | 2 KIT in 1 CARTON (50090-4487-0) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Aug 29, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Humira
- Generic name (nonproprietary)
- adalimumab
- Dosage form
- Kit
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125057
- Marketing start
- Listing expires
- Identifiers
- Product ID 50090-4487_9083dedd-bfe5-47f1-b940-72101f343d9dSPL ID 9083dedd-bfe5-47f1-b940-72101f343d9dSPL set ID a06a9aec-fd5b-4c3e-a81f-eb46bb384100RxCUI 797544, 1655726, 1655728
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090448700followed by a unit qualifier and the quantityPackage 50090-4487-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
HUMIRA is a tumor necrosis factor (TNF) blocker indicated for: Rheumatoid Arthritis (RA) ( 1.1 ) : reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. Juvenile Idiopathic Arthritis (JIA) ( 1.2 ) : reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older. Psoriatic Arthritis (PsA) ( 1.3 ) : reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA. Ankylosing Spondylitis (AS) ( 1.4 ) : reducing signs and…
Excerpt only. Read the full label for complete information.
About NDC 50090-4487
- What is NDC 50090-4487?
- 50090-4487 is the product NDC for Humira (adalimumab) kit, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Humira (Adalimumab).
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Humira?
- 14 other product NDCs are listed under this name. See all Humira NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Humira products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-124 | 83457-0124-02 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-243 | 83457-0243-02 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-554 | 83457-0554-02 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-616 | 83457-0616-02 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-817 | 83457-0817-02 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0616 | 00074-0616-0200074-0616-71 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0817 | 00074-0817-02 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0124 | 00074-0124-0100074-0124-0200074-0124-03+2 more |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-1539 | 00074-1539-03 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-2540 | 00074-2540-01 |
Other NDCs under BLA 125057
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0124 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0243 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0554 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0616 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-0817 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-1539 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-2540 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-3799 |
| Humiraadalimumab | — | Kit | AbbVie Inc. | 0074-4339 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-124 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-243 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-554 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-616 |
| Humiraadalimumab | — | Kit | Cordavis Limited | 83457-817 |